Lilly Bolsters Oncology Pipeline with US$8 B Takeover of Loxo Oncology
By Subham Nandi
Pharma Deals Review: Vol 2019 Issue 1 (Table of Contents)
Published: 12 Jan-2019
DOI: 10.3833/pdr.v2019.i1.2395 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In the second largest oncology acquisition of the year so far, Eli Lilly has agreed to acquire Loxo Oncology in a deal worth up to US$8 B...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS